According to market.us, the Biomaterials Market is anticipated to achieve a substantial valuation of approximately USD 540.5 Billion by 2032, marking a significant increase from its 2022 value of USD 155.9 Billion. This growth trajectory reflects a compound annual growth rate (CAGR) of 13.6% over the forecast period.